Fluoroquinolone Label Warning Strengthened by FDA Fluoroquinolone Label Warning Strengthened by FDA
The FDA updated fluoroquinolone labeling to warn against routine use in patients with acute bacterial sinusitis, acute exacerbation of chronic bronchitis, and uncomplicated urinary tract infections. < br / > < i > News Alerts < /i >
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Infectious Diseases News Alert Source Type: news
More News: Bronchitis | Drugs & Pharmacology | Infectious Diseases | Sinusitis | Urinary Tract Infections | Warnings